NCT03375892

Brief Summary

This study aims to discover more about radiation techniques for people treated for left-sided breast cancer that minimizes exposure to the heart, as noted by mean heart dose.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 18, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 3, 2018

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2021

Completed
Last Updated

January 13, 2025

Status Verified

January 1, 2025

Enrollment Period

3.1 years

First QC Date

December 13, 2017

Last Update Submit

January 10, 2025

Conditions

Keywords

radiationDeep Inspiration Breath Holdstage Istage IIstage IIa

Outcome Measures

Primary Outcomes (1)

  • Changes in EKG parameters prior to, during or after radiation therapy.

    Changes in QRS wave form will be categorized as 'present' or 'absent' based on the presentation (or lack) of a r' wave, or notched r or s wave on the EKG tracing. QRS-T angle will be measured in degrees.

    Baseline, 6 weeks, 6 months and 12 months

Secondary Outcomes (5)

  • Change in mitochondrial energy production, as measured in leukocytes (peripheral blood mononuclear cells) from patients prior to and after undergoing radiation therapy.

    baseline, 6 weeks, and 6 and 12 months post-radiation therapy

  • Changes in left ventricular ejection fraction prior to, during or after radiation therapy.

    Baseline and 12 months

  • Changes in left atrial volume prior to, during or after radiation therapy.

    Baseline and 12 months

  • Left ventricular wall thickness prior to, during or after radiation therapy.

    Baseline and 12 months

  • Arterial and aortic stiffness.

    Baseline and 12 months

Study Arms (4)

Prone Position with DIBH

ACTIVE COMPARATOR

For prone positioning, patients will be positioned with alpha cradle casts, and a prone breast board.

Other: Deep Inspiration Breath Hold during Radiation

Supine Position with DIBH

ACTIVE COMPARATOR

For the supine positioning, patients will be positioned with the breast board currently in use in the Department of Radiation Oncology.

Other: Deep Inspiration Breath Hold during Radiation

Prone Position with no DIBH

ACTIVE COMPARATOR

For prone positioning, patients will be positioned with alpha cradle casts, and a prone breast board.

Other: Free breathing during radiation

Supine Position with no DIBH

ACTIVE COMPARATOR

For the supine positioning, patients will be positioned with the breast board currently in use in the Department of Radiation Oncology.

Other: Free breathing during radiation

Interventions

The DIBH technique involves the patient breathing to a specified threshold and then holding that level of inspiration during every radiation therapy field delivered.

Prone Position with DIBHSupine Position with DIBH

The patient will be instructed to breathe freely.

Prone Position with no DIBHSupine Position with no DIBH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have a pathologically proven diagnosis of left-sided invasive breast cancer or ductal carcinoma in situ receiving breast/chestwall irradiation +/- regional nodal irradiation, or a right-sided invasive ductal cancer status post-mastectomy or lumpectomy who will be receiving breast/chest wall and nodal irradiation.
  • Patients must have undergone breast conserving surgery (i.e. lumpectomy, partial mastectomy) or mastectomy prior to enrollment.
  • Patients must be 18 years of age or older.
  • Study entry must be prior to CT simulation.
  • Per Medical College of Wisconsin Department of Radiation Oncology Standard of Care, women of childbearing potential must be non-pregnant and non-lactating and willing to use medically acceptable forms of contraception during radiation therapy. Patients under age 50 with a uterus and ovaries must have a negative serum pregnancy test within one week of planned CT simulation per Radiation Oncology Departmental guidelines prior to CT simulation.
  • Patients must provide study specific informed consent prior to study entry.
  • Patients must be able to hold their breath long enough to undergo CT simulation in DIBH (ten to fifteen seconds). The patient should also affirm they can lie in the prone position. This will be determined by the treating radiation oncologist, as per current standard of care.

You may not qualify if:

  • Patients who are unable to hold their breath long enough to undergo CT simulation in DIBH. While this may affect patients with chronic obstructive pulmonary disease (COPD) and/or other respiratory conditions, the presence of these comorbidities alone will not exclude patients from enrollment so long as they can maintain breath hold long enough to perform DIBH.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Froedtert Hospital and Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeBreast Carcinoma In SituCarcinoma in SituNeoplasms, Ductal, Lobular, and Medullary

Study Officials

  • Adam Currey, MD, PhD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 13, 2017

First Posted

December 18, 2017

Study Start

March 3, 2018

Primary Completion

March 21, 2021

Study Completion

March 21, 2021

Last Updated

January 13, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations